FDA Investigator Jaison J Eapen
Jaison J Eapen has conducted inspections on 14 sites in 3 countries as of 05 May 2021. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
14
Last Inspection Date:
05 May 2021
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Israel
FDA Investigators that have inspected at least one site in common with Jaison J Eapen:
Alan P Kurtzberg,
Alice S Tsao,
Anastasia M Shields,
Anita R Michael,
Ann M Stewart,
Ashley L Reiber,
Audrey Thereset Uy,
Brian R Yaun,
Bryan J Love,
Carrie L Doupnik,
Catherine O Lamptey,
Chaltu Nwakijra,
Charanjeet Jassal,
Charisse K Green,
Charles M Edwards,
Clarice J Ahn,
Colleen M Damon,
Craig D Zagata,
Cynthia A Harris, MD, RN,
David A Oluwo,
Deborah J Parris,
Debra J Bennett,
Denise M Digiulio,
Dennis L Doupnik,
Deyaa Shaheen,
Diane T Bargo,
Dianne H Milazzo,
Dongping Dai, PhD,
Douglas A Campbell,
Dr. Robert C Horan, MD,
Edouard Viard,
Emest F Bizjak,
Eric L Dong, BS,
Felix Maldonado,
Gale L Glinecki,
Gary J Lehr,
Gayle S Lawson,
Jai P Singh,
James A Liubicich,
James C Illuminati,
James M Simpson,
Jay T Wong,
Jean Blackston Hill,
Joanne Heim,
Joanne M Hajoway,
John Dan,
Jonathan W Chapman,
Julianne C Mccullough,
Junho Pak,
Karen A Briggs,
Karyn M Campbell,
Kathleen M Jordan,
Keith M Reilly,
Kenneth Nieves,
Kevin A Gonzalez,
Kristen D Evans,
Kristina J Donohue,
Kristina Mjoyce Pittman,
Lauren N Barber,
Lawrence W Farina,
Lisa B Orr,
Lisa M Bellows,
Lori S Lawless,
Luella J Rossi,
Luis A Dasta,
Marea K Harmon,
Matthew R Noonan,
Michael Gurbarg,
Michael L Casner,
Michael O Idowu,
Michele Gottshall,
Nancy M Espinal,
Nebil A Oumer,
Peter M Trunk,
Pratik S Upadhyay, DDC,
Qin Xu,
Rachel C Harrington,
Robert B Shibuya, MD,
Robert C Steyert,
Robert J Maffei,
Sam Pepe,
Sena G Dissmeyer,
Shari L Kahn,
Sharon K Thoma, PharmD,
Stephanie L Shapley,
Stephen J Koniers,
Steven P Donald,
Susan F Laska, MS,
Suwaskie S Smith,
Suzanne M Healy,
Suzanne M Muchene,
Temar Q Williams,
Thomas E Friel,
Toyin B Oladimeji,
Tracy M Portelli,
Uduak M Inokon,
Vlada Matusovsky,
Walter L Fava,
Yuyan Liang,
Zhongren Wu
Jaison J Eapen's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2019 | FDA 483 | NOXELL CORPORATION - Form 483, 2019-02-25 |
January, 2020 | FDA 483 | ZOETIS INC - Form 483, 2020-01-10 |
January, 2020 | FDA 483 | Abbey Color Incorporated - Form 483, 2020-01-29 |
February, 2020 | FDA 483 | Cosmetic Essence, LLC - Form 483, 2020-02-28 |
March, 2016 | FDA 483 | TIME CAP LABORATORIES, INC - Form 483, 2016-03-10 |
July, 2019 | FDA 483 | Frontida BioPharm, LLC - Form 483, 2019-07-19 |
September, 2019 | FDA 483 | C-Care LLC - Form 483, 2019-09-16 |
July, 2019 | FDA 483 | Sasa Cosmetics - Form 483, 2019-07-02 |
July, 2019 | EIR | Frontida BioPharm, LLC - EIR, 2019-07-19 |
January, 2020 | EIR | Abbey Color Incorporated - EIR, 2020-01-29 |
March, 2016 | EIR | TIME CAP LABORATORIES, INC - EIR, 2016-03-10 |
May, 2021 | FDA 483 | Microbac Laboratories, Inc. - Form 483, 2021-05-24 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more